Is Community Based Monitoring of Diabetic Maculopathy and Pre-proliferative Diabetic Retinopathy Safe?
NCT06955611 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2025-05-02
Summary
To assess a pathway using opticians based in their practices and a 'virtual' review by a consultant ophthalmologist, based in the hospital to assess suspected diabetic maculopathy. We want to know if this pathway works, is it acceptable to people with diabetes and what the changes might mean in terms of the outcomes for patients and NHS resources and cost?
Screening by Diabetic Eye Service Wales currently involves taking and as-sessing 2-D (dimensional) digital photographs of the back of the eye (reti-na). Leakage from damaged blood vessels can cause swelling within the central part of the retina, known as maculopathy. This swelling cannot be seen on traditional 2-D images.
Diagnosing maculopathy requires a 3-D camera and a technique known as Optical Coherence Tomography (OCT). OCT is not part of routine screening but, is available in the Hospital Eye Service (HES) and many optician prac-tices. If any changes are seen in the macular region of the retina on 2-D images, the patient will require an OCT scan to see if there is any in-creased thickness. Many patients do not have increased thickness and not everyone with diabetic retinopathy has maculopathy.
Currently after screening, patients who have macular changes that suggest possible maculopathy are referred to the HES for OCT imaging. Many of these patients will not have increased thickness and the appointment could have been better used to see a different patient with increased thickness that requires treatment.
The new pathway that will be investigated in this study involves trained opticians in practices that have an OCT camera taking the required 3-D images and carrying out the initial examination. The images and patient record will then be reviewed by an ophthalmologist working virtually, to decide the management plan. If this pathway is safe and acceptable to people with diabetes, it would reduce the pressure on HES clinics. It will also develop new skills for opticians and allow people to be seen closer to their home, reducing the stress that referrals can create and lowering the carbon footprint of the service.
Conditions
- Diabetes Mellitus
- Diabetic Retinopathy
- Diabetic Maculopathy
Interventions
- OTHER
-
Community based optometry with Virtual Review
Community based OCT imaging with optometrist and virtual review by ophthalmologist
- OTHER
-
Usual Care
Hospital eye services review conducted by an ophthalmologist
Sponsors & Collaborators
-
Swansea University
collaborator OTHER -
Hywel Dda Health Board
lead OTHER
Principal Investigators
-
Eirini Skiadaresi, MD · Hywel Dda University Health Board
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-11-20
- Primary Completion
- 2025-08-31
- Completion
- 2025-09-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
NCT01625598 ·Status: COMPLETED
-
The Diabetic Retinopathy Screening, Prevention and Control Program
NCT04240652 ·Status: RECRUITING
-
Screening For Diabetic Macular Edema Among Diabetic Patients Using Optical Coherence Tomography
NCT03240458 ·Status: UNKNOWN
-
Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy
NCT06582472 ·Status: RECRUITING
-
Community Screening Study of Diabetic Retinopathy in Tianjin in 2024
NCT06478407 ·Status: RECRUITING
-
Skin and Retina Microvascular Endothelial Function in Healthy, Insulin Resistant and Type 2 Diabetic Subjects
NCT01241370 ·Status: COMPLETED
-
Severe Proliferative Diabetic Retinopathy
NCT01115257 ·Status: COMPLETED ·Phase: NA
-
Assessment Of Diabetic Maculopathy Changes After Phacoemulsification by Using Optical Coherence Tomography
NCT05547789 ·Status: UNKNOWN
-
Expansion of Integrated AI Solution for Diabetic Retinopathy Screening in Thailand
NCT05527535 ·Status: UNKNOWN
-
Shanghai Beixinjing Diabetic Eyes Study
NCT03571217 ·Status: UNKNOWN
-
Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography
NCT01790945 ·Status: UNKNOWN
-
Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With Diabetes
NCT00119535 ·Status: COMPLETED ·Phase: NA
-
Automated AI-based System for Early Diagnosis of Diabetic Retinopathy
NCT05324189 ·Status: UNKNOWN
-
Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy
NCT06305143 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Evaluation of Vitrectomy for Diabetic Macular Edema
NCT00709319 ·Status: COMPLETED
-
A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy
NCT02963441 ·Status: COMPLETED
-
Phenotyping Diabetic Retinopathy
NCT00840541 ·Status: COMPLETED
-
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes
NCT07270133 ·Status: NOT_YET_RECRUITING
-
A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
NCT06701721 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Decision Support Algorithm to Predict Diabetic Retinopathy
NCT03769948 ·Status: UNKNOWN
-
A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema
NCT02876393 ·Status: COMPLETED
-
Diabetic Retinopathy and Visual Function Study
NCT00001346 ·Status: COMPLETED
-
Prophylactic Effect of Conbercept Intravitreal Injection at the Conclusion of Cataract Surgery for Diabetic Macular Edema
NCT04668703 ·Status: UNKNOWN ·Phase: NA
-
Patient Navigator Intervention for Diabetic Retinopathy
NCT05188703 ·Status: COMPLETED ·Phase: NA
-
Study on Exosome Changes in Patients With Proliferative Diabetic Retinopathy
NCT06198543 ·Status: NOT_YET_RECRUITING